|
KMID : 1202020130060010056
|
|
Journal of Korean Thyroid Association
2013 Volume.6 No. 1 p.56 ~ p.63
|
|
|
Incidence & Prevalence of Hyperthyroidism and Preference for Therapeutic Modalities in Korea
|
|
Seo Gi-Hyeon
Kim Sun-Wook
Chung Jae-Hoon
|
|
|
Abstract
|
|
|
|
Background and Objectives: The incidence and prevalence of hyperthyroidism has been reported to be 0.2-0.9/1000 population/year and 5-10/1000 population in foreign countries, respectively. However, there has been no nationwide survey to evaluate them in Korea. Therefore, this study was conducted to investigate the incidence and prevalence of hyperthyroidism in Korea using medicare claims data provided by the Health Insurance Review and Assessment Service. Preference for its therapeutic modalities and its change were also analyzed. Materials and Methods: This study was performed in 308,584 (men 86,460, women 222,124) Korean patients with hyperthyroidism treated from January 2006 to June 2012. Patients with past history of hyperthyroidism were not included. Results: The incidence of hyperthyroidism was 0.72/1000 population/year (men 0.40, women 1.03), and its prevalence was 3.40/1000 population (men 2.09, women 4.70) in Korea. Its peak prevalence was detected between 45 and 49 years of age. Among 177,487 patients with hyperthyroidism treated from 2007 to 2011, anti-thyroid drugs were prescribed in 97.9%, and radioiodine therapy and surgery were finally performed in 8.2% and 0.9%, respectively. The prescription of propylthiouracil (PTU) has been reduced from 63.3% in 2007 to 42.9% in 2011, but the use of methimazole (MMI) increased from 33.9% in 2007 to 54.8% in 2011. Primary physicians preferred PTU to MMI, but physicians in general hospitals preferred MMI to PTU. Conclusion: This is the first nationwide report to investigate the incidence and prevalence of hyperthyroidism in Korea.
|
|
|
KEYWORD
|
|
|
Hyperthyroidism, Incidence, Prevalence, Propylthiouracil, Methimazole
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
 
|
|